- Home
- COEP vs GCV Comparison
COEP vs GCV Comparison
Compare COEP & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- GCV
- Stock Information
- Founded
- COEP 2017
- GCV 1988
- Country
- COEP United States
- GCV United States
- Employees
- COEP N/A
- GCV N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- GCV Finance/Investors Services
- Sector
- COEP Health Care
- GCV Finance
- Exchange
- COEP Nasdaq
- GCV Nasdaq
- Market Cap
- COEP 72.1M
- GCV 85.1M
- IPO Year
- COEP N/A
- GCV N/A
- Fundamental
- Price
- COEP $17.71
- GCV $4.13
- Analyst Decision
- COEP
- GCV
- Analyst Count
- COEP 0
- GCV 0
- Target Price
- COEP N/A
- GCV N/A
- AVG Volume (30 Days)
- COEP 44.7K
- GCV 57.9K
- Earning Date
- COEP 11-14-2025
- GCV 01-01-0001
- Dividend Yield
- COEP N/A
- GCV 13.04%
- EPS Growth
- COEP N/A
- GCV N/A
- EPS
- COEP N/A
- GCV N/A
- Revenue
- COEP $500,996.00
- GCV N/A
- Revenue This Year
- COEP N/A
- GCV N/A
- Revenue Next Year
- COEP N/A
- GCV N/A
- P/E Ratio
- COEP N/A
- GCV N/A
- Revenue Growth
- COEP N/A
- GCV N/A
- 52 Week Low
- COEP $2.31
- GCV $3.15
- 52 Week High
- COEP $19.19
- GCV $4.58
- Technical
- Relative Strength Index (RSI)
- COEP 65.07
- GCV 42.94
- Support Level
- COEP $15.52
- GCV $4.02
- Resistance Level
- COEP $18.00
- GCV $4.15
- Average True Range (ATR)
- COEP 1.25
- GCV 0.08
- MACD
- COEP 0.34
- GCV -0.01
- Stochastic Oscillator
- COEP 92.40
- GCV 33.33
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.